KENT KRESA

Chairman

MannKind Corp.

Kent Kresa has been chairman of MannKind Corp. since 2016 and has served on the company’s board of directors since 2004. MannKind is a biopharmaceutical company focused on the development and commercialization of therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Kresa, a former chairman and chief executive of Northrop Grumman Corp., also serves as chairman emeritus of the company. He helped transform Northrop Grumman from a boutique military contractor to a broad-based $28 billion enterprise with 120,000 employees. Kresa is chairman of the advisory board of Lincoln Laboratory at Massachusetts Institute of Technology, a member of the board of overseers at Keck School of Medicine of USC, chairman emeritus of the Caltech board of trustees and director emeritus of the Los Angeles Music Center